Remove 2028 Remove Healthcare Provider Remove Sales
article thumbnail

Medical Sales Opportunities for the Next Decade

Every Ancillary

Most seasoned medical sales representatives have carried several different products or services over their careers. Between emerging technologies, expiring patents, and ever-changing insurance coverage, the role of a medical sales professional is to constantly adapt and learn new things. Gives you an area of expertise.

article thumbnail

Growing pains: how the pharmaceutical industry can hire and retain talent during industry boom

pharmaphorum

Everything from transitioning to virtual meetings with healthcare providers, to navigating the logistics of supply chain disruptions, has permanently altered pharma operations – many would say for the better. A new operating model for pharma shifted priorities and forced companies to rethink their organisational strategies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Making Sense of the Latest Changes to the Market Access Landscape

PM360

Most immediately, it will add confusion in the healthcare space,” explains Daniel Sontupe, Associate Partner, Managing Director, The Bloc Value Builders. This will create confusion in the marketplace and may possibly lead to delivery of misinformation to healthcare providers (HCPs) regarding a brand’s drug coverage,” Bambalas says.

article thumbnail

Non-Invasive Healthcare Products Buy and Sell

Contrarian Sales Techniques

According to various market research reports, the global non-invasive medical devices market was valued at approximately USD 45 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of over 6% from 2021 to 2028. This growth is driven by several factors, including: 1.

article thumbnail

Biosimilars: The Future of Affordable Biologic Therapies

Pharmaceutical Representative Training

The existence of biosimilars is meant to address both the cost and access of biologics in the healthcare industry. [1] Their biosimilar market trends over 2024 have shown a 53% average increase in market share within 5 years post launch of each product, while average sale prices also decreased by around 53% within 5 years. [3]